UBS OCONNOR LLC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$654,416
-4.5%
59,764
+15.5%
0.02%
-27.3%
Q2 2023$685,355
-27.3%
51,764
-25.3%
0.02%
-24.1%
Q1 2023$943,173
-99.9%
69,300
+20.5%
0.03%
+38.1%
Q3 2022$1,095,000,000
+1.2%
57,500
+9.5%
0.02%
+31.2%
Q2 2022$1,082,000,00052,5000.02%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$29,989,69616.06%
MPM BioImpact LLC 1,745,943$19,118,0765.10%
Saturn V Capital Management LP 994,756$10,892,5784.56%
Boxer Capital, LLC 1,804,058$19,754,4351.05%
RA Capital Management 4,417,259$48,368,9860.95%
683 Capital Management, LLC 810,000$8,869,5000.69%
Ikarian Capital, LLC 346,471$3,793,8570.46%
Ikarian Capital, LLC 3,056$3,346,3200.40%
BVF INC/IL 1,259,476$13,791,2620.37%
DAFNA Capital Management LLC 98,560$1,079,2320.34%
View complete list of ITEOS THERAPEUTICS INC shareholders